Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Current Deferred Revenue (2016 - 2025)

Mesa Laboratories (MLAB) has disclosed Current Deferred Revenue for 13 consecutive years, with $14.6 million as the latest value for Q4 2025.

  • Quarterly Current Deferred Revenue fell 0.96% to $14.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.6 million through Dec 2025, down 0.96% year-over-year, with the annual reading at $14.8 million for FY2025, 5.63% down from the prior year.
  • Current Deferred Revenue hit $14.6 million in Q4 2025 for Mesa Laboratories, up from $14.3 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $16.3 million in Q3 2022 to a low of $8.8 million in Q1 2021.
  • Historically, Current Deferred Revenue has averaged $14.1 million across 5 years, with a median of $14.7 million in 2024.
  • Biggest five-year swings in Current Deferred Revenue: surged 71.69% in 2022 and later fell 11.99% in 2023.
  • Year by year, Current Deferred Revenue stood at $12.5 million in 2021, then skyrocketed by 30.04% to $16.2 million in 2022, then fell by 11.56% to $14.4 million in 2023, then rose by 2.46% to $14.7 million in 2024, then dropped by 0.96% to $14.6 million in 2025.
  • Business Quant data shows Current Deferred Revenue for MLAB at $14.6 million in Q4 2025, $14.3 million in Q3 2025, and $15.1 million in Q2 2025.